Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
The Journal of Pathology · 2025-03 · 265 (3) · 385-399
DOI: 10.1002/path.6395 ↗At a glance
Journal article in The Journal of Pathology, published online on 2025-01-23. Written by Xunxi Lu and 7 co-authors. Institution: Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China. Major MEDLINE topics: Triple Negative Breast Neoplasms, Cancer-Associated Fibroblasts, Extracellular Matrix. Cited 53 times so far (Crossref); 55 references. Funded by: National Natural Science Foundation of China, Sichuan Science and Technology Program, Post-Doctor Research Project, West China Hospital, Sichuan University.
Abstract (original language)
The impact of high heterogeneity of cancer‐associated fibroblasts (CAFs) on triple‐negative breast cancer (TNBC) immunotherapy response has not been fully elucidated, restricting progress in precision immuno‐oncology. We integrated single‐cell transcriptomic data from 18 TNBC patients and analyzed fibroblast subpopulations. Extracellular matrix CAFs (ecmCAFs) were identified as a fibroblast subpopulation with distinct ECM‐associated characteristics. The ecmCAFs were significantly enriched in TNBC patients with residual disease after neoadjuvant immunotherapy and contributed to a fibrotic tumor microenvironment and T‐cell exclusion. Secreted phosphoprotein 1 ( SPP1 ) positive macrophages (SPP1 + Mφs) were closely localized to ecmCAFs and produced more transforming growth factor beta ( TGFB1 ), interleukin 1 beta ( IL1B ), and SPP1 under hypoxic conditions. SPP1 + Mφs were found to facilitate the differentiation of normal breast fibroblasts to ecmCAFs, thus promoting ECM remodeling and stromal fibrosis. Our work revealed the critical role of ecmCAFs in generating a desmoplastic architecture and driving immunosuppression in TNBC. © 2025 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China.
- Laboratory of Breast Pathology and Artificial Intelligence, West China Hospital, Sichuan University, Chengdu, PR China.
- Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, PR China.
- Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, PR China.
ORCID profiles: Xunxi Lu, Zongchao Gou, Hong Chen
Funding
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Post-Doctor Research Project, West China Hospital, Sichuan University
Cite
APA
Lu, X., Gou, Z., Chen, H., Li, L., Chen, F., Bao, C., Bu, H., & Zhang, Z. (2025). Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology, 265(3), 385-399. https://doi.org/10.1002/path.6395
Vancouver
Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology. 2025;265(3):385-399. doi:10.1002/path.6395
BibTeX
@article{Lu2025,
author = {Lu, Xunxi and Gou, Zongchao and Chen, Hong and Li, Li and Chen, Fei and Bao, Chunjuan and Bu, Hong and Zhang, Zhang},
title = {Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer},
journal = {The Journal of Pathology},
year = {2025},
volume = {265},
number = {3},
pages = {385--399},
doi = {10.1002/path.6395}
}
EUVIMED